Vitamin D supplements in people with sarcoidosis and low vitamin D
Tests vitamin D supplements versus placebo in people with sarcoidosis and low vitamin D.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Vitamin D Homeostasis in Sarcoidosis
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 90 people, planned
- Started
- 1 Jul 2010
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ergocalciferol
- Placebo
- Calcium Citrate with Vitamin D2
- Record updated
- 3 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with sarcoidosis who are in stable health. It studies vitamin D levels, and people with low vitamin D get either vitamin D or a placebo (dummy pill).
- Age
- 21 years and older
- Sex
- All sexes
- Disease stage
- Sarcoidosis in a stable condition: no hospital stay or emergency room visit in the previous 3 months.
- Biomarker or test result
- Normal calcium level in the blood (serum ionized calcium). Vitamin D level decides the group: low vitamin D or normal vitamin D.
Main reasons for not taking part
- Hospital stay or emergency room visit in the previous 3 months
- Active lung or body-wide infection
- Another active inflammatory disease
- Active cancer
- High calcium level in the blood
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Stable medical condition defined as no hospitalization or emergency room visit in the previous 3 months
- No evidence of active pulmonary or systemic infection
- No other active inflammatory disease,
- No active malignancy
- Normal serum ionized calcium level
Who cannot take part
- Hospitalization or emergency room visit in the previous 3 months
- Evidence of active pulmonary or systemic infection
- Evidence of active other inflammatory disease
- Evidence of active malignancy
- Elevated serum ionized calcium level
Where in United States
- University of Texas Southwestern Medical Center, and Parkland Health and Hospital SystemDallas, United StatesContact: Connie Hsia, MD (principal investigator)Taking people
About the trial
What the trial wants to find out
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.
The 3 groups in the trial
- Low vit-D, ErgocalciferolTreatment being tested
Low serum vitamin D level, split by use or non-use of systemic corticosteroid. Vitamin D2 (Ergocalciferol) 50,000 units will be given by mouth once a week for 12 weeks, then once a month for 12 weeks. Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Treatment: Ergocalciferol and Calcium Citrate with Vitamin D2
- Low vit-D, PlaceboPlacebo, for comparison
Low serum vitamin D level, split by use or non-use of systemic corticosteroid. Placebo capsules of identical size and appearance will be given by mouth once a week for 12 weeks, then once a month for 12 weeks. Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Treatment: Placebo and Calcium Citrate with Vitamin D2
- Normal vit-D, controlOther group
Normal serum vitamin D level, split by use or non-use of systemic corticosteroid. Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Treatment: Calcium Citrate with Vitamin D2
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Vitamin D Homeostasis in Sarcoidosis
- Plain-language title
- Vitamin D supplements in people with sarcoidosis and low vitamin DGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 3 September 2026